Dyslipidemia News and Research

RSS

Dyslipidemia is a disruption in the amount of lipids in the blood.

New book discusses pharmacotherapeutic management of cardiovascular complications

Cardiovascular disease is a complexity of conditions comprising heart failure, cardiomyopathy, congenital heart disease and coronary heart disease etc. They impose severe health complications and remain challenge on treatments for the affected patients

22 Oct 2020

Sebum changes in COVID-19 patients, for future testing and prognosis

Now, a new study published on the preprint server medRxiv in September 2020 shows that sebum lipids change in COVID-19. This could help develop a cheap and straightforward method of non-invasive diagnosis.

5 Oct 2020

Vitamin D deficiency during early development can influence metabolic health

Using a zebrafish model, researchers from North Carolina State University have found that vitamin D deficiency during early development can disrupt the metabolic balance between growth and fat accumulation.

29 Sep 2020

Study: 5 to 10% of surgically induced weight loss linked with cardiovascular benefits

A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health.

23 Sep 2020

Carotid artery calcification seen in radiographs linked with coronary artery disease, oral infections

The calcification of the carotid artery is a sign of advanced arteriosclerosis, which may be associated with chronic coronary artery disease (CAD) and can lead to death. Such calcification can be seen in regular oral panoramic radiography.

16 Sep 2020

Seroconversion marks recovery from COVID-19

Nine months into the COVID-19 pandemic, scientists are still seeking to understand the protective immunity that develops against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the increasing need for serological tests in epidemiology, their clinical value has not been fully established. A new paper published in the Journal of Medical Virology in September 2020 describes the relationship of COVID-19 disease symptoms with the serological status over time.

11 Sep 2020

Researchers identify shared molecular roots between lipid dysfunction and autism

Researchers at Harvard Medical School, Massachusetts Institute of Technology and Northwestern University have identified a subtype of autism arising from a cluster of genes that regulate cholesterol metabolism and brain development.

18 Aug 2020

AI-enhanced precision medicine approach lays groundwork for identification of autism subtype

A novel precision medicine approach enhanced by artificial intelligence (AI) has laid the groundwork for what could be the first biomedical screening and intervention tool for a subtype of autism, reports a new study from Northwestern University, Ben Gurion University, Harvard University and the Massachusetts Institute of Technology.

10 Aug 2020

Disruptions to lipid metabolism after childbirth predict future diabetes risk

Scientists have found that disruptions to the metabolism of lipids occur after childbirth in women with gestational diabetes who go on to develop type 2 diabetes.

4 Aug 2020

Researchers identify differences in clinical features of non-obese patients with NAFLD

Researchers from the University of Tsukuba identify differences in the clinical features of non-obese patients with non-alcoholic fatter liver disease based on their sex and body mass index.

2 Aug 2020

COVID-19-associated stroke patients have higher risk for severe disability and death

Acute ischemic strokes (AIS) associated with COVID-19 are more severe, lead to worse functional outcomes and are associated with higher mortality , according to new research published yesterday in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

12 Jul 2020

Patient-friendly method of measuring retinal vessel diameters indicates cardiovascular risk

Peter Maloca, group leader at IOB for Ophthalmic Imaging, together with Konstantin Gugleta, senior attending physician at the University Hospital Eye Clinic Basel and Henner Hanssen, Head of Preventive Sports Medicine & Systems Physiology, Department of Sport, Exercise and Health, University of Basel, investigated whether an easy-to-use method of measuring retinal vessel diameters can indicate cardiovascular risk.

2 Jun 2020

Does abdominal fat affect COVID-19 outcomes?

As the COVID-19 pandemic seems to be slowing down in some parts of the world slightly but accelerating in others, scientists are investigating the role played by a host of factors that might impact the final outcome. A new study published on the preprint server medRxiv* in May 2020 examines the role of abdominal fat (visceral obesity, VO) in severe COVID-19.

21 May 2020

DZD researchers discover additional genetic cause for non-alcoholic fatty liver disease

In Germany about 18 million people suffer from non-alcoholic fatty liver. The causes of this disease are manifold and include environmental as well as genetic factors.

19 May 2020

Computer program analyzes blood plasma to identify weight gain biomarkers

Researchers at the University of Campinas in São Paulo State, Brazil, have developed a computer program that analyzes molecules in blood plasma to search for biomarkers that identify individuals who are at risk of becoming overweight and developing obesity-related diseases.

10 Mar 2020

Menopause age not associated with heart disease finds study

There has been conflicting evidence regarding early menopause and an increased risk for heart disease among women. This connection has been attributed to the lowering of female hormone estrogen levels in the blood.

26 Feb 2020

High intake of sugary drinks may influence risk for dyslipidemia

Middle-aged and older adults who drank sugary beverages daily were at greater risk of developing abnormal cholesterol and triglyceride levels compared to those who rarely drank those beverages, according to a new epidemiological study published today in the Journal of the American Heart Association.

26 Feb 2020

Sugary drinks have a negative impact on blood cholesterol, which increases heart disease risk

Drinking 12 ounces of sugary drinks more than once per day is linked to lower levels of high-density lipoprotein cholesterol (HDL-C), ("good" cholesterol), and higher levels of triglycerides, in middle-aged and older adults, both of which have been shown to increase risk of cardiovascular disease.

26 Feb 2020

Tea drinkers live longer new study shows

Green tea, native to China and India, has gained immense popularity for its health benefits. Now, there are more reasons to drink green tea, as scientists found consuming tea at least three times a week could help reduce the risk of premature death, living a longer and healthier life.

10 Jan 2020

Initiatives led by pharmacists can contribute to the prevention of cardiovascular disease

With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in the British Journal of Clinical Pharmacology indicates that initiatives--such as patient education, medication review, and physical assessments--led by pharmacists can make important contributions to the prevention of cardiovascular disease.

28 Nov 2019

Dyslipidemia News and Research

New book discusses pharmacotherapeutic management of cardiovascular complications

Sebum changes in COVID-19 patients, for future testing and prognosis

Vitamin D deficiency during early development can influence metabolic health

Study: 5 to 10% of surgically induced weight loss linked with cardiovascular benefits

Carotid artery calcification seen in radiographs linked with coronary artery disease, oral infections

Seroconversion marks recovery from COVID-19

Researchers identify shared molecular roots between lipid dysfunction and autism

AI-enhanced precision medicine approach lays groundwork for identification of autism subtype

Disruptions to lipid metabolism after childbirth predict future diabetes risk

Researchers identify differences in clinical features of non-obese patients with NAFLD

COVID-19-associated stroke patients have higher risk for severe disability and death

Patient-friendly method of measuring retinal vessel diameters indicates cardiovascular risk

Does abdominal fat affect COVID-19 outcomes?

DZD researchers discover additional genetic cause for non-alcoholic fatty liver disease

Computer program analyzes blood plasma to identify weight gain biomarkers

Menopause age not associated with heart disease finds study

High intake of sugary drinks may influence risk for dyslipidemia

Sugary drinks have a negative impact on blood cholesterol, which increases heart disease risk

Tea drinkers live longer new study shows

Initiatives led by pharmacists can contribute to the prevention of cardiovascular disease

Could beta-blockers be a potential treatment for COVID-19?

The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why

The Prospects of Semaglutide for Treatment of Type 2 Diabetes Patients

Latest News